Amirreza Solhpour, MD

Dr. Amir Solhpour is an advanced structural interventional cardiologist trained at the prestigious Texas Medical Center, the largest medical center in the world, located in Houston, Texas where the first heart transplant in the US was performed. He was selected as the clinical and research cardiology fellow of the year several times during his training and received several awards. He has six board certificates which is rare among cardiologists. He is American board-certified in internal medicine, cardiology, interventional cardiology, echocardiography, nuclear cardiology and is a Registered Physician For Vascular Interpretation (RPVI exam-certified). In addition to extra training in lipid and cholesterol management, his subspecialty includes management of various cardiac and vascular conditions using minimally invasive catheter-based therapy. This includes a wide range of procedures such as transcatheter aortic valve replacement (TAVR) for severe symptomatic aortic valve stenosis, the MitraClip procedure to percutaneously repair leaky mitral valve, left atrial appendage closure using the WATCHMAN device, and closure of PFO or ASD. He is also specialized in treating aortic aneurysm using a minimally invasive approach (EVAR). As an interventional cardiologist, he also treats various life threatening conditions such as cardiac arrest or cardiogenic shock using percutaneous ECMO placement to bypass both lung and heart in an emergency situation as a bridge to the final treatment. Dr. Solhpour also treats life-threatening pulmonary embolism or large burden thrombus in the arterial system of the lower extremity via placement of EKO catheter and using reduced dose targeted fibrinolytic. He also treats coronary artery diseases, carotid diseases and lower extremity vascular blockages using balloons and stents.
Dr. Solhpour has published more than 30 papers in peer-reviewed journals and has presented several times in national and international conferences including the American Heart Association and the American College of Cardiology. Dr. Solhpour just recently wrote a chapter as first author about “Percutaneous Left Ventricular Assist Devices” in one of the internationally well-known book references for interventional cardiologists, entitled “Cardiovascular Catheterization and Interventions” published in 2017. Dr. Solhpour pioneered both MitraClip and WATCHMAN procedures at Glendale and currently serves as the director of the Structural Heart Disease Program at Adventist Health Glendale.